The present study was designed to: i) to assess the changes in IL-17A expression, atrial inflammatory responses, fibrosis, along with arrhythmia vulnerability induced by transesophageal burst pacing in rats with SP and ii) to determine whether the blockade of IL-17A prevents AF by inhibiting inflammation and fibrosis in rats with SP. Here, IL17A is linked to atrial fibrillation.